Unknown

Dataset Information

0

International Forum for the Advancement of Diabetes Research and Care, April 29-30, 2011, Athens, Greece.


ABSTRACT: The International Forum for the Advancement of Diabetes Research and Care brought together distinguished international experts in diabetes to discuss diverse trends and emerging issues in diabetes therapy and management. The plenary sessions on the first day focused on trends in insulin therapy, the role of glucagon-like peptide-1 receptor agonists in diabetes treatment, the relationship between diabetes and cardiovascular risk, and the challenges associated with the development of clinically relevant treatment guidelines. Interactive breakout sessions addressed the following topics: microvascular complications of diabetes; the need for a team approach to patient education; optimal management of Asian people with diabetes; the role of continuous glucose monitoring in assessing glucose variability; and lessons learned from biosimilar drugs. The plenary sessions on the second day covered self-monitoring of blood glucose, treatment and prevention of type 1 diabetes, and future directions for diabetes therapy. The meeting represented an excellent forum for the presentation of new research and the exchange of ideas aimed at improving outcomes for people with diabetes.

SUBMITTER: Bolli GB 

PROVIDER: S-EPMC3160268 | biostudies-literature | 2011 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

International Forum for the Advancement of Diabetes Research and Care, April 29-30, 2011, Athens, Greece.

Bolli Geremia B GB   Deeb Larry C LC   Garg Satish K SK   Leahy John L JL   Mazze Roger S RS   Owens David R DR   Riddle Matthew C MC   Southerland Phil P   Strock Ellie S ES  

Diabetes technology & therapeutics 20110901 9


The International Forum for the Advancement of Diabetes Research and Care brought together distinguished international experts in diabetes to discuss diverse trends and emerging issues in diabetes therapy and management. The plenary sessions on the first day focused on trends in insulin therapy, the role of glucagon-like peptide-1 receptor agonists in diabetes treatment, the relationship between diabetes and cardiovascular risk, and the challenges associated with the development of clinically re  ...[more]

Similar Datasets

| S-EPMC3707411 | biostudies-literature
| S-EPMC6179947 | biostudies-literature
| S-EPMC8441545 | biostudies-literature
| S-EPMC4895366 | biostudies-literature
| S-EPMC5508335 | biostudies-literature
| S-EPMC4550654 | biostudies-literature
| S-EPMC6383788 | biostudies-literature
| S-EPMC2777312 | biostudies-literature
| S-EPMC8002050 | biostudies-literature
| S-EPMC8321698 | biostudies-literature